Topics: Pharmacogenomics, Pharmacoepidemiology, DRUG SPECIFICITY, receptor classification, drug concentration, drug effect, spare receptors, COMPETITIVE ANTAGONISM, Irreversible Competitive Antagonism, Partial Agonists, Constitutive Receptor Activation, Inverse Agonists, two-state receptor model, Biased Agonism, Allosteric Modulation, Chemical Antagonism, Pharmacokinetic Antagonism, Receptor–Response Linkage, Physiological Antagonism, Desensitisation, Tolerance, Altered Drug Metabolism, Binding Reaction, Drug–Receptor Interactions, Receptor mechanisms, Ion Channels, Enzymes, Receptor Proteins, Receptor Heterogeneity, Ligand-Gated Ion Channels, Gating Mechanism, G Protein–Coupled Receptors, Proteinase-Activated Receptors, G proteins, phospholipase C, inositol phosphate system, Inositol phosphates, intracellular calcium, Diacylglycerol, protein kinase, MAP kinase system, GPCR desensitisation, Biopharmaceuticals, Chemical Mediators, Presynaptic Modulation, Postsynaptic Modulation, Cholinergic transmission, Nicotinic Receptors, Acetylcholine, Muscarinic Agonists, Muscarinic Antagonists, Ganglion Stimulants, Ganglion-Blocking Drugs, Neuromuscular-Blocking Drugs, Non-Depolarising Blocking Agents, Depolarising Blocking Agents, Cholinesterase Reactivation, Noradrenergic transmission, Adrenoceptor Agonists, α-Adrenoceptor antagonists, 5-Hydroxytryptamine, migraine, Adenosine, purine, Histamine, local hormone, Eicosanoids, Prostanoids, Leukotrienes, Platelet-Activating Factor, Bradykinin, peptide, Neuropeptides, Cytokine, Interferon, Cannabinoids, Endocannabinoids, Nitric oxide, Ischaemic Heart Disease, Antidysrhythmic Drugs, Myocardial Contraction, Anti-Anginal Drugs, Organic Nitrates, Calcium Antagonists, Endothelin, Vasoactive Drugs, Vasodilator Drugs, heart failure, Atherosclerosis, lipoprotein metabolism, Lipoprotein Transport, Lipid-Lowering Drugs, Fibrates, Haemostasis and thrombosis, Blood Coagulation, Warfarin, Platelet Adhesion, Platelet Activation, Antiplatelet Drugs, Adenosine Receptor Antagonists, Fibrinolysis, Thrombolysis, Fibrinolytic Drugs

Topics: Autonomic Pharmacology, autonomic drugs, Cholinoceptor-Activating Drug, Cholinesterase-Inhibiting Drug, Cholinoceptor-Blocking Drugs, Adrenoceptor Agonists Drug, Sympathomimetic Drug, Adrenoceptor Antagonist Drug, cardiovascular-renal drug, Antihypertensive Agents, Vasodilators, Treatment of Angina Pectoris, Heart Failure, Cardiac Arrhythmias, Diuretic Agents, actionson smooth muscle, central nervous system, inflammation, gout, endocrine drugs, chemotherapeutic drugs, toxicology, Heavy Metal Intoxication, Chelators, Poisoned Patient, Beta-Lactam, Cell Wall Antibiotics, Membrane-Active Antibiotics, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, Oxazolidinones, Aminoglycosides, Spectinomycin, Sulfonamides, Trimethoprim, Quinolones, Antimycobacterial Drugs, Antifungal Agents, antiviral agents, Antimicrobial Agents, Disinfectants, Antiseptics, Sterilants, Antimicrobial Agents, Antiprotozoal Drugs, Antihelminthic Drugs, Cancer Chemotherapy, Immunopharmacology, Hypothalamic Hormones, Pituitary Hormones, Thyroid drugs

Topics: amoebiasis, antiamebic drugs, amebic colitis, MIXED ANTIAMEBIC DRUGS, Mixed amebicides, METRONIDAZOLE, LUMINAL ANTIEMEBIC DRUGS, DILOXANIDE FUROATE, IODOQUINOL, PAROMOMYCIN, Luminal amebicides, tissue amebicides, DEHYDROEMETINE, EMETINE, stystemic amebicides, CHLOROQUINE, TETRACYCLINES

Topics: Sedative-Hypnotic Drugs, benzodiazepines, gamma-aminobutyric acid, Benzodiazepine Binding Site Ligands, Antiseizure Drugs, Phenytoin, Carbamazepine, Seizure Disorders, Status epilepticus

Topics: Psychopharmacology, Drugs, brain, behavior, Nervous System, chemical signaling, Catecholamines, Neurotransmitter Synthesis, Neurotransmitter Receptors, Synaptic Plasticity, Catecholamine Synthesis, Dopaminergic System, Noradrenergic System, Serotonin, Serotonin Synthesis, Serotonergic System, Acetylcholine, Cholinergic System, Glutamate, drug abuse, drug addiction, alcohol, Alcohol Use Disorder, Opioids, Narcotic Analgesics, Opioid Receptors, Endogenous Neuropeptides, Psychomotor Stimulants, Cocaine, Amphetamine, Nicotine, Caffeine, cigarette smoking, vaping, Marijuana, Cannabinoids, Hallucinogens, Ketamine, Mescaline, Psilocybin, Inhalants, Anabolic–Androgenic Steroids, Anxiety Disorder, Affective Disorders, Antidepressants, Mood Stabilizers, Schizophrenia, Antipsychotic Drugs, Neurodegenerative Diseases, Parkinson’s Disease, Alzheimer’s Disease, Huntington’s Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis

Topics: hypolipademic drugs, hyperlipidemias, Bile acid–binding resins, statins, Lipoprotein lipase activators, fibrates, Nicotinic acid, Lipolysis, triglyceride synthesis inhibitor, niacin, nicotinic acid, Ezetimibe, Cholesterol absorption inhibitor, Omega-3 fatty acids

Topics: enzymes, antiparasitic drugs

Topics: antimicrobial resistance, antiparasitic resistance, penicillins, tetracycline, cephalosporin, amphotericin B, Aminoglycosides, antifungal drugs, azole compounds, allyamines, Antimalarial resistance, Chloroquine resistance, Antifolate resistance, Artemisinin resistance, ANTIPARASITIC DRUG RESISTANCE, Trichomoniasis, Trichomonas resistance, Leishmaniasis, African trypanosomiasis, Trypanosomiasis drug resistance

Topics: drug dependence, psychoactive drug, psychotropic substance, CNS stimulants, xanthine, cocaine, Ephedrine, Benzodiazepines, sedatives, hallucinogens, KETAMINE, PHENCYCLIDINE, cannabinoids, Recreational drugs, inhalant

Topics: Intracellular steroid, nuclear steroid, Thiourea agents, Beta-blockers, GOITROGENIC DRUGS, HYPOTHYROIDIXM